Novel methicillin resistance gene mecD in clinical Macrococcus caseolyticus strains from bovine and canine sources. by Schwendener, Sybille et al.
1Scientific RepoRts | 7:43797 | DOI: 10.1038/srep43797
www.nature.com/scientificreports
Novel methicillin resistance gene 
mecD in clinical Macrococcus 
caseolyticus strains from bovine 
and canine sources
Sybille Schwendener, Kerstin Cotting & Vincent Perreten
Methicillin-resistant Macrococcus caseolyticus strains from bovine and canine origins were found 
to carry a novel mecD gene conferring resistance to all classes of β-lactams including anti-MRSA 
cephalosporins. Association of β-lactam resistance with mecD was demonstrated by gene expression 
in S. aureus and deletion of the mecD-containing island in M. caseolyticus. The mecD gene was located 
either on an 18,134-bp M. caseolyticus resistance island (McRImecD-1) or a 16,188-bp McRImecD-2. Both 
islands were integrated at the 3′ end of the rpsI gene, carried the mecD operon (mecD-mecR1m-mecIm), 
and genes for an integrase of the tyrosine recombinase family and a putative virulence-associated 
protein (virE). Apart from the mecD operon, that shared 66% overall nucleotide identity with the mecB 
operon, McRImecD islands were unrelated to any mecB-carrying elements or staphylococcal cassette 
chromosome mec. Only McRImecD-1 that is delimitated at both ends by direct repeats was capable of 
circular excision. The recombined excision pattern suggests site-specific activity of the integrase and 
allowed identification of a putative core attachment site. Detection of rpsI-associated integrases in 
Bacillus and S. aureus reveals a potential for broad-host range dissemination of the novel methicillin 
resistance gene mecD.
Macrococcus is evolutionarily closely related to the genus Staphylococcus, but possesses a distinctly smaller 
genome with a size of 2.1 Mb in the species M. caseolyticus1. There are currently eight species included in the 
genus Macrococcus, namely M. caseolyticus, M. equipercicus, M. bovicus, M. carouselicus, M. brunensis, M. hajekii, 
M. lamae and M. canis2–4. Macrococcus is mainly found commensally on the surface of the body of animals 
and has also been isolated from raw milk and dairy products5–7. Methicillin-resistant strains were reported for 
M. caseolyticus from chicken, bovine milk and humans1,8–10 and for other Macrococcus species from dogs11,12.
Methicillin resistance in Staphylococcus and Macrococcus is due to the production of an alternative 
penicillin-binding protein (PBP2a, also called PBP2′ or MecA, MecB, and MecC) that has low affinity for almost 
all β -lactams13,14. In the presence of drug concentrations that inactivate native PBPs through irreversible acyla-
tion, PBP2a conserves its transpeptidase activity allowing cell-wall biosynthesis to continue15. PBP2a is encoded 
by a structural mec gene so far identified as mecA, mecB and mecC, and its presence can be predicted pheno-
typically using a screen for cefoxitin or oxacillin resistance16. The mec gene is organized in an operon with its 
regulators mecR1 and mecI coding for an integral-membrane sensor/transducer and a transcriptional repressor, 
respectively17. The mec-mecR1-mecI gene complex is homologous to blaZ-blaR1-blaI controlling β -lactamase 
expression through an inducible proteolytic pathway18 and crosstalk between the systems has been observed19–22.
The classical mecA gene is carried by a unique class of mobile genetic elements, the staphylococcal cassette 
chromosome mec (SCCmec)23, originally found in methicillin-resistant S. aureus (MRSA)24. Since then, a wide 
structural diversity of SCCmec elements has been described in both coagulase-positive and coagulase-negative 
staphylococci that carry either the mecA or the mecC gene25. The SCCmec elements are site-specifically integrated 
into the chromosomal orfX gene, have characteristic flanking repeat sequences, a mec gene complex and cassette 
chromosome recombinase(s) (ccr) responsible for integration/excision of the element.
In Macrococcus, methicillin resistance has been associated with the mecB gene (formerly mecAm), a distantly 
related mecA homologue1. It is present in a mec gene complex (blaZm-mecB-mecR1m-mecIm) which includes the 
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regulators and additionally the blaZ homologue blaZm. The mecB gene complex was originally found associ-
ated with transposon Tn6045 located on either large plasmids or integrated into the chromosome as part of 
a SCCmec-like element in M. caseolyticus1,8. Recently, a SCCmec carrying mecB independent of Tn6045 was 
reported in a hemolytic Macrococcus strain (M. canis sp. nov., formerly identified as M. caseolyticus)4,12.
Since 2014, several cases of bovine mastitis and an infection in a dog caused by methicillin-resistant 
mecB-negative M. caseolyticus strains were observed by our diagnostic unit at the Institute of Veterinary 
Bacteriology in Bern, Switzerland. This prompted us to investigate the nature of this β -lactam resistance by whole 
genome sequencing and gene expression which revealed the new methicillin resistance gene mecD on novel 
resistance islands.
Results and Discussion
Identification of a novel acquired PBP2a in M. caseolyticus. M. caseolyticus strains IMD0819 and 
IMD0473 were isolated from bovine mastitis milk and strain KM0211 from an infection site of a dog (Table 1). 
They all exhibited resistance to penicillin, cefoxitin and oxacillin but did not carry any of the described methi-
cillin-resistance genes (Table 1). Whole genome sequencing and tblastn analysis using PBP2a encoded by mecA, 
mecB and mecC as queries revealed a novel mec gene homologue in the three β -lactam-resistant strains but not 
in the β -lactam-sensitive M. caseolyticus strain KM1352 (Table 1). The mec gene was designated mecD according 
to the SCCmec guidelines for reporting new mecA gene homologues which defines a new mec gene type if the 
nucleotide (nt) sequence shares less than 70% identity to any known mec genes13. The mecD gene was identical 
in strains IMD0819, IMD0473 and KM0211 and shared 69% nt identity and 63% amino acid (aa) identity with 
mecB of M. caseolyticus strain JCSC54021 and less than 62% nt and 53% aa identity with all other PBP2a of the 
Mec family (Fig. 1).
Regulation and expression of mecD. The mecD gene complex. The mecD gene was preceded by two 
regulatory genes mecR1m and mecIm transcribed in the opposite direction. The gene organization was similar 
M. caseolyticus strain Origin/region Resistance phenotype Resistance genes Reference
CCUG 15606 T Bovine milk — ND 2
KM1352 Healthy dog/Jura — — This study
IMD0819 Bovine mastitis milk/Fribourg PEN, FOX, OXA, TET, KAN, TMP, STR mecD, tet(L), ant(4′ )-Ia, dfrK, str This study
IMD0473 Bovine mastitis milk/Bern PEN, FOX, OXA, TET, KAN, STR mecD, ant(4′ )-Ia, tet(L), str This study
KM0211 Dog, otitis/Bern PEN, FOX, OXA, STR mecD, str This study
Table 1.  Origin and phenotypic and genotypic characteristics of M. caseolyticus strains used in this study. 
ND: not determined. Abbreviation of antimicrobials: PEN, penicillin; FOX, cefoxitin; OXA, oxacillin; TET, 
tetracycline; KAN, kanamycin; TMP, trimethoprim. Antibiotic resistance genes and functions: mecD, penicillin-
binding protein 2a; tet(L), tetracycline efflux protein; ant(4′ )-Ia, kanamycin nucleotidyltransferase; dfrK, 
dihydrofolate reductase; str, streptomycin nucleotidyltransferase.
Figure 1. Phylogenetic tree of mec genes encoding PBP2a. Evolutionary analysis was performed for 
nucleotide sequences using the UPGMA method in MEGA756. The percentage of nucleotide (nt) and amino 
acid (aa) identity between mecD and other mec genes was determined by sequence alignment with Clustral 
OMEGA [http://www.ebi.ac.uk/Tools/msa/clustalo/]. *) mecC1 of S. xylosus S04009 does not encode a 
functional PBP2a due to a frameshift mutation close to the 5′ end of the gene.
www.nature.com/scientificreports/
3Scientific RepoRts | 7:43797 | DOI: 10.1038/srep43797
to regulated systems containing other mec structural genes or blaZ. Comparison of mecD regulatory genes with 
these systems demonstrated that they possessed the highest sequence similarity with those of mecB, namely 61% 
nt identity with the homologous sensor/transducer gene mecR1m and 70% with the transcriptional repressor 
gene mecIm of M. caseolyticus JCSC5402 (Supplementary Figs S1 and S2). The genomes of the mecD-containing 
M. caseolyticus strains contained no further mec/bla regulators and no homologous genes to the β -lactamase blaZ 
or the antirepressor mecR2. The absence of a β -lactamase was confirmed by negative results in the nitrocefin test.
Promoter-operator structure. Analysis of the 171-bp intergenic region between mecD and mecR1m-mecIm 
revealed a divergent promoter pair for bidirectional transcription in an overlapping 32-bp fragment (Fig. 2). 
Promoters were predicted using the program BPROM that recognizes − 35 and − 10 consensus sequences for the 
bacterial sigma factor 7026. In addition, an operator site was identified using the consensus sequence for mec/bla 
divergons defined by Garcia-Castellanos27 (Fig. 2). The operator site is located within the mecR1m and mecD pro-
moter region suggesting that binding of one MecIm dimer can repress transcription of mecD and mecR1m-mecIm 
simultaneously. The perfect consensus sequence for the mec/bla divergon found in M. caseolyticus suggests pos-
sible control of mecD expression by other MecI/BlaI proteins as is the case in S. aureus where BlaI and MecI can 
exchange with each other20,28. In addition to the palindromic sequences present in the mec operator, perfect and 
imperfect inverted repeats were found in the region between the mecD promoter and start site that might function 
as regulatory sequence in genomic DNA or RNA transcript (Fig. 2).
mecD regulators: MecR1m and MecIm. Resistance to β -lactams mediated by blaZ and mecA is controlled 
through an inducible proteolytic signal transduction pathway in S. aureus18,29. The mecD regulators were therefore 
analyzed for the presence of aa-patterns and domains known to play a functional role in this pathway. MecR1m 
contained a putative C-terminal penicillin-binding domain (PBD) involved in β -lactam sensing (Ser315-Lys561). 
The three signature motifs conserved within PBPs/β -lactamases were also present30: motif 1 including the cat-
alytic serine (SxxK) was found at aa position 369–372 (Ser-Thr-Tyr-Lys), motif 2 (SxN) at position 417–419 
(Ser-Val-Asn) and motif 3 (KTG[T/S]) at position 504–507 (Lys-Thr-Gly-Thr). The protein also showed a classi-
cal zinc-binding motif (HExxH) at position 183–187 (His-Glu-Ile-Thr-His) and a potential autolytic cleavage site 
(Lys272-Arg273) for activation of the metalloproteinase according to BlaR18.
The MecIm repressor was predicted to contain an N-terminal DNA-binding domain (Met1-Val73) with a 
winged helix-turn-helix structure matching entries cl21459 and pfam12802 in the Conserved Domain Database 
(CDD) (https://www.ncbi.nlm.nih.gov/cdd/). The putative recognition helix (Ser41-Asn56) was the most con-
served segment that shared 80% sequence identity with the recognition helix α 3 of the MecI protein of S. aureus 
N31527, while the overall aa identity was much lower with only 47% identity (Supplementary Fig. S2). The poten-
tial cleavage site for MecIm repressor inactivation was found between Asn101-Phe102 corresponding to the sites 
demonstrated in staphylococcal MecI and BlaI18,29.
MecD. The mecD gene encodes a 678-aa protein with a C-terminal transpeptidase domain (Ser330-Glu678) 
(CDD: pfam00905 and cl21491) that contains the three signature motifs conserved within PBPs (see paragraph 
mecD regulators). Motif 1 was present at position 406–409 (Ser-Thr-Gln-Lys), motif 2 at position 465–467 
(Ser-Asp-Asn) and motif 3 at position 605–608 (Lys-Thr-Gly-Thr) followed by an alanine typically found in 
class B PBPs. The N-terminal section consisted of a transmembrane-helix (Lys7-Leu25, N-terminus inside) as 
predicted using TMpred software (http://www.ch.embnet.org/) and a non-penicillin binding domain (nPBD) 
(Glu27-Leu329) with an N-terminal extension subdomain (Glu27-Ala140) (CDD: pfam05223) typically found 
in PBP2a. Compared to MecA, MecD showed a distantly related nPBD and a more conserved transpeptidase 
domain with 37% and 64% aa identity, respectively.
mecD-mediated resistance phenotype. Minimal inhibitory concentrations (MICs) of different classes of β -lactam 
antibiotics were determined for the three mecD-positive M. caseolyticus strains and the mecD-negative strains 
KM1352 and CCUG 15606 T (Table 2). As control, two mecD-deletion mutants of strain IMD0819 were included. 
Figure 2. Divergent promoters and operator sequence in the intergenic region between mecR1m and mecD 
genes of M. caseolyticus. The − 10 and − 35 promoter sequences are underlined. Start codons and ribosomal 
binding sites (RBS) are in bold type. The operator sequence is highlighted in green and inverted repeats marked 
by arrows. The consensus sequence [A/G]NATTACA[A/T]NTGTA [A/G][T/G]NT (with bases acceptable 
for one given position between square brackets and “N” for any base) was used to identity operator sequence 
recognized by MecI/BlaI repressors27. The sequence is shown for M. caseolyticus IMD0819 (Genbank acc. no 
KY013611, position 15264–15440).
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These mutants had lost either an 18,134-bp (strain IMD0819_20) or a 20,907-bp (strain IMD0819_33) genomic 
element containing the mecD gene (see paragraph construction of McRImecD-1 deletion variants). Compared to 
the mecD-negative strains, the mecD-containing strains IMD0819, IMD0473 and KM0211 showed several fold 
higher MICs of penicillins including the penicillinase-resistant drugs oxacillin and temocillin. The MICs were 
also higher for 2nd (cefoxitin), 3rd (cefotaxime and ceftazidime) and 4th (cefepime) generation cephalosporins as 
well as for carbapenems (ertapenem, imipenem and meropenem). The MIC for the anti-MRSA cephalospor-
ins, ceftobiprole and ceftaroline were also at least 16-fold (ceftobiprole) and 8-fold (ceftaroline) higher in the 
mecD-containing strains. The transpeptidase domain of MecD provides similar residues to those identified to 
be important for ceftobiprole binding within the active site region of MecA (Tyr446, Thr600, Met641)31, namely 
Phe449, Thr608, Met650. The Tyr to Phe substitution in MecD should not decrease ceftobiprole binding since 
only aromatic stacking interaction was observed between Tyr446 and ceftobiprole31. The reason for reduced sus-
ceptibility may be associated with other structural differences between MecA and MecD, e. g. the diverse nPBDs. 
The nPBD (also called allosteric domain) of MecA is involved in allosteric control of the transpeptidase’s active 
site32. Ceftaroline binds to allosteric sites in the nPBD, causing a rearrangement of salt bridges and predisposes 
MecA to acylation by a second β -lactam molecule32. The nPBD of MecD is only distantly related to that of MecA 
and neither equivalent residues for ceftaroline binding nor a similar scatter of charged aa are obvious which ques-
tions an analogue allosteric control mechanism for MecD.
The complete structure of mecR1m-mecIm suggests inducible mecD expression in the presence of β -lactams. To 
study mecD expression, two plasmids were constructed using S. aureus-E. coli shuttle vector pTSSCm33. Plasmid 
pTSSCm-D1 contained mecD with its upstream 171-bp intergenic region and plasmid pTSSCm-D2 contained 
the entire mecD operon including the regulator genes mecR1m and mecIm. Both plasmids were electroporated into 
S. aureus RN4220 and selected for tetracycline resistance encoded on the vector. Transformants were only readily 
obtained with pTSSCm-D2 which contained the regulated mecD operon but not with pTSSCm-D1 which carried 
unregulated mecD. RN4220 colonies harboring pTSSCm-D1 were only obtained using Chromagar MRSA II for 
selection. These colonies grew slowly when re-streaked on agar containing tetracycline and only recovered their 
normal growth after several passages. They presented high level β -lactam resistance after the first subculturing 
but the level of resistance decreased after subsequent passages (e.g. MIC of oxacillin dropped from 32 mg/L to 
2 mg/L). These results indicated that constitutive mecD expression has a deleterious effect and expression level 
needs to be downregulated for growth in the absence of β -lactams in S. aureus. Similarly, instability of unreg-
ulated plasmid-carried mecA was also observed in S. aureus, where the presence of mec or bla regulators was 
demonstrated to stabilize mecA integrity and expression34.
RN4220 cells carrying unregulated mecD on the plasmid pTSSCm-D1 presented MICs of β -lactams all 
above the values measured for RN4220 alone or those containing the empty vector (Table 2). Cells harboring 
pTSSCm-D2 with the regulated mecD showed 8-fold increase in the MIC of cefoxitin and at least 4-fold increased 
values for oxacillin, ceftaroline and cefotaxime, but no increase of MIC for ceftobiprole, ertapenem and imipenem 
Strain/plasmid Characteristics mec genes
MIC of β-lactam antibiotics (mg/L)
PEN OXA TMC FOX CTX CAZ FEP CBP CRL ETP IPM MEM
M. caseolyticus
 CCUG 15606 T Type strain — ≤ 0.25 ≤ 0.25 32 1 0.5 4 0.5 ≤ 0.125 ≤ 0.125 0.25 ≤ 0.12 0.06
 KM1352 Field strain — ≤ 0.25 0.5 64 2 1 8 1 ≤ 0.125 0.25 0.5 ≤ 0.12 0.12
 IMD0819 Field strain mecD-mecR1m-mecIm 8 128 > 128 64 > 64 > 128 > 32 2 1 > 2 8 4
 IMD0473 Field strain mecD-mecR1m-mecIm 8 > 128 > 128 64 > 64 > 128 > 32 4 2 > 2 4 8
 KM0211 Field strain mecD-mecR1m-mecIm 16 > 128 > 128 128 > 64 > 128 > 32 8 2 > 2 > 16 8
 IMD0819_20 IMD0819 Δ mcRImecD-1
— ≤ 0.25 ≤ 0.25 32 1 0.5 4 0.5 ≤ 0.125 ≤ 0.125 0.25 ≤ 0.12 0.12
 IMD0819_33
IMD0819 
Δ mcRImecD-1-
McCIIMD0819
— ≤ 0.25 ≤ 0.25 32 1 0.5 4 0.5 ≤ 0.125 ≤ 0.125 0.25 ≤ 0.12 0.12
S. aureus
 RN4220 Recipient strain — ≤ 0.25 ≤ 0.25 ND 2 ND ND ND 0.5 0.25 ND ND ND
 RN4220/pTSSCm
RN4220 with 
S. aureus-E. coli 
shuttle vector 
pTSSCm
— ≤ 0.25 ≤ 0.25 64 2 1 8 2 0.5 0.25 0.12 ≤ 0.12 0.12
 RN4220/pTSSCm-D1
RN4220 with 
mecD cloned into 
pTSSCm
mecD 2 2 > 128 32 16 64 8 1 1 2 0.5 2
 RN4220/pTSSCm-D2
RN4220 with 
mecD, mecR1m 
and mecIm cloned 
into pTSSCm
mecD-mecR1m-mecIm 0.5 1 > 128 16 4 16 4 0.5 1 0.12 ≤ 0.12 0.25
Table 2.  Antimicrobial susceptibility of Macrococcus caseolyticus and Staphylococcus aureus strains to 
β-lactams as determined by broth microdilution. Abbreviations: PEN, benzylbenicillin; OXA, oxacillin; 
TMC, temocillin; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; CBP, ceftobiprole; CRL, 
ceftaroline; ETP, ertapenem; IPM, imipenem; MEM, meropenem.
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indicating that these β -lactams are poor inducer for mecD expression in S. aureus. Importantly, in the presence 
of mecD, cefoxitin MIC values were always measured above the EUCAST breakpoint defined for MRSA screen-
ing (MIC: R > 4)35, also confirming the production of a low affinity PBP2a in RN4220. Compared to S. aureus, 
phenotypic resistance mediated by mecD was remarkably higher in M. caseolyticus with all the tested β -lactams 
(Table 2). Production of MecD seems to be well adapted for M. caseolyticus and to be suboptimal for S. aureus. 
Expression of an additional PBP may interfere with cell wall metabolism and needs to be regulated. In S. aureus, 
MecI functions as a strong transcriptional repressor and prompt induction and expression of mecA is usually 
not achieved if it is solely controlled through the mecR1-mecI regulators19,20. Enhanced expression of β -lactam 
resistance is observed for mecA controlled through the blaZ regulators and also the anti-repressor mecR219–21,36. 
It might be possible that the mecD phenotype could be stronger in another S. aureus background than RN4220, 
that lacks both mecR2 and blaR1-blaI.
Characterization of chromosomal resistance islands carrying mecD. McRImecD-1. The mecD gene 
was located on a nearly identical 18,134-bp element (99.97% nt identity) in strains IMD0819 and KM0211. The 
element was designated M. caseolyticus resistance island mecD one (McRImecD-1). In both strains, McRImecD-1 
was integrated into the 3′ end of the 30S ribosomal protein S9 gene (rpsI), flanked by imperfect extended direct 
repeats (DR1 and DR2) of either 160, 161 or 163 bp (Fig. 3). At the 5′ end, McRImecD-1 carried an open read-
ing frame (orf) encoding an integrase (int) of the tyrosine recombinase family and two upstream divergent ori-
ented orfs coding for putative DNA-binding proteins with helix-turn-helix (HTH) motifs, which belong either 
to the transcriptional Cro/C1-type (orf3) or to the excisionase/Xis family (orf4). The gene organization resem-
bles the int-stl(-str)-xis structure found in SaPIs of S. aureus, but further characteristics of these phage-related 
Figure 3. Structures of McRImecD-1 and McRImecD-2 and flanking sequences. Comparison was performed 
with sequences of M. caseolyticus strains JCSC5402 (Genbank acc. no. NC_011999, position 215180–250630), 
IMD0473 (Genbank acc. no KY013610), IMD0819 (Genbank acc. no KY013611), KM0211 (Genbank acc. no 
KY013612) and KM1352 (Genbank acc. no KY013613) using Easyfig software57. Gray areas indicate regions 
with between 68% to 100% nucleotide sequence identity. Regions encompassing McRImecD-1, McRImecD-2 and 
McCIIMD0819 are indicated by horizontal black lines and flanking direct repeats (DRs) by vertical blue lines. The 
open reading frames (orfs) are represented by arrows: mecD, mecR1m and mecIm are shown in red, orfs encoding 
integrase (int) or transposase (tnp) are shown in yellow, reverse transciptases (rt) in beige, orfs associated with 
restriction-modification in green and virulence-associated orfs in mauve; the orfs occurring in all  
M. caseolyticus strains are shown in black and additional strain-specific orfs in blue. The primers used in this 
study are indicated by small black arrowheads (a), mecD-F; (b), mecD-R; (c), truA-F; (d), s66-R; (e), int-0819-F; 
(f), int-0473-F; (g), araC-F; (h), orf21-R; (i), orf20-F; (j), cop-R) and cleavage sites for restriction endonucleases 
HindIII (H3) and HincII (H2) and EcoRI (E1) by thin vertical lines.
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chromosomal island like pri, rep, pif and terS genes37 were absent in McRImecD-1. Besides the mec operon, 
McRImecD-1 contained 17 predicted orfs, including one gene encoding a potential virulence factor (virE), genes 
for restriction-modification system (hsmRI and hsrRI) and for a putative DNA recombination-mediator protein 
(dprA) (Fig. 3). VirE contained the virulence-associated protein E domain (CDD: pfam05272) and shared 36% 
aa identity with the VapE protein encoded on SePIfusB-857 of S. epidermidis NTUH-85738. The DNA modification 
methyltransferase HsmMI and the restriction endonuclease HsrRI displayed 46 and 65% aa identity to those 
enzymes of the BsuBI/PstI type II system of B. subtilis, respectively39. DprA of McRImecD-1 was up to 51% iden-
tical to homologues of Bacillus species (WP_034289281) but only 30% identical to the native homologue of M. 
caseolyticus (GenBank: WP_012656740). DprA proteins are ubiquitously found in bacteria. In Bacillus subtilis, 
DprA has been shown to be involved in natural competence and mediating homologous recombination through 
recruitment of RecA to ssDNA40,41.
McRImecD-1 represents a new element that shows only fragmentary sequence identity with GenBank entries. 
The fragment containing the int gene (position 7261–8482 in IMD0819, GenBank acc. no KY013611) shared 
77% nt identity with a unique integrase in the chromosome of M. caseolyticus JCSC5402 (Fig. 3) (GenBank acc. 
no NC_011999) and in the draft genome of S. aureus 930918–3 (ABFA01000015.1). In addition, the genome of 
M. caseolyticus JCSC5402 and S. aureus 930918–3 shared 85 and 88% identity with a fragment containing the 
orf8 of McRImecD-1 (position 12182–12418 in IMD0819), respectively. The same fragment was also found with 
81% identity in the draft genome of S. hominis LRKNS031 (LXRS01000085.1). The fragment containing the mec 
operon of McRImecD-1 (position 13185–17475 in IMD0819) shared 66% overall identity with the mecB-containing 
fragment of the plasmid pMCCL2 of M. caseolyticus JCSC5402 (AP009486.1), indicating a novel mec operon 
type13 on the new element McRImecD-1.
Downstream of McRImecD-1, strain IMD0819 contained 4 additional orfs (orf21-orf24) and another DR (DR3) 
not present in the other M. caseolyticus strains (Fig. 3). The 404-bp DR3 shared 91% identity overall with a 
405-bp region containing DR2. The segment between DR2 and DR3 represented a 2,773-bp chromosomal island 
(CI) with three orfs and was called McCIIMD0819. Together, McRImecD-1 and McCIIMD0819 constituted a composite 
island in IMD0819. While only partial sequence similarity (coverage < 20%) was found between McCIIMD0819 and 
Staphylococcus/Bacillus GenBank entries, McCIIMD0819 showed 97% overall identity to E. faecium strains UC7265 
(JRHQ01000038.1) and UC7267 (ASAM01000028.1). The three orfs (orf21-orf23) of McCIIMD0819 encode hypo-
thetical proteins: ORF21 contained a putative domain of bacteriocin-processing endopeptidases (CDD: cl00296) 
and ORF23 contained a domain for AraC family transcriptional regulators (CDD: COG3708). ORF24, situated 
downstream of McCIIMD0819, encoded a putative AAA family ATPase that shared 44% aa identity with a protein 
of a Bacillus species (WP_069304013).
McRImecD-2. McRImecD-2 consisted of a 16,188-bp insert in the chromosome of IMD0473. It was delimitated by 
the attachment (att) site defined at the 3′ end of rpsI (see paragraph excision and circularization of McRImecD-
1-McCIIMD0819 subunits) and the s66 family peptidase gene (s66) identified as a core genome sequence in all other 
M. caseolyticus strains (Fig. 3). A DR at the right side of McRImecD-2 was missing as well as a chromosomal seg-
ment including the cop gene suggesting that deletion took place at this locus in IMD0473. The mecD-containing 
segment of McRImecD-2 was similar to that of McRImecD-1 (position 11280–17867 in IMD0819) comprising orf6 
to orf14 (99.97% nucleotide identity) (Fig. 3). However, McRImecD-2 contained different integrase and virE genes 
with 77% identity and 75% identity to those of McRImecD-1 at the left side, and a completely different sequence 
on the right side, which carried a putative transposase and two possible reverse transcriptases (RTs). The trans-
posase displayed similarity to those of the IS30 family (CDD: COG2826), and was also present in the genome of 
IMD0819. It shared up to 51% aa identity with transposases found in Staphylococcus and Enterococcus species. 
The RTs displayed the RT motifs 3, 4 and 5 and a domain typically found in bacterial retrotransposons and retrons 
(CDD: cd01646)42. Both proteins showed less than 40% aa identity with all other GenBank entries.
The chromosomally integrated structures of McRImecD-1 and McRImecD-2 were confirmed by HindIII and 
HincII restriction analysis of long-range PCR products spanning mecD with the 5′ end region and 3′ end region 
of the islands, respectively (Fig. 3). The amplicons were obtained using primer pairs mecD-R and truA-F and 
mecD-F and s66-R (Fig. 3 and Supplementary Table S1). The structure of the mecD-negative strain KM1352 was 
verified by EcoRI digest of the PCR product amplified with primers truA-F and s66-R.
Mobility of McRImecD-1 and McRImecD-2. Site-specific integrases associated with mecD. The integrase sit-
uated on the 5′ end of the mecD resistance islands may catalyze integration and excision of the elements. The 
integrases in McRImecD-1 and McRImecD-2 differed slightly from each other, sharing 81% aa identity. Both consisted 
of a 388-aa protein that contained a N-terminal SAM-like domain found in phage integrases (CDD: pfam14569) 
and the conserved residues described for tyrosine recombinase in the C-terminal section, including the active site 
tyrosine at position 367 and two invariant arginines at position 210 and 33443. The integrase of McRImecD-2 was 
98% identical to the integrases found in the chromosome of M. caseolyticus JCSC5402 and in the draft genome 
of S. aureus 930918–3, both strains being negative for mecD. In JCSC5402, the integrase was associated with a 
unique sequence that encodes a putative type III restriction modification system and was also delimitated by DRs 
(Fig. 3). In S. aureus 930918–3 and the M. caseolyticus strains JCSC5402, IMD0819, KM0211 and IMD0473, the 
integrase was inserted downstream of the rpsI gene, suggesting a site-specific activity of the enzyme. Distantly 
related integrases that share up to 46% aa identity with the integrases of M. caseolyticus strains were also found 
next to the rpsI gene in Bacillus species (Fig. 4a). Compared with other integrases of the tyrosine recombinase 
family, mecD-associated integrases showed 40 to 43% identity to the integrases of SaPIbov1/2 and of unchar-
acterized inserts in S. intermedius, S. hominis and S. pseudintermedius (Fig. 4a). The analysis suggests that the 
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integrases of mecD resistance islands have a common ancestor with rpsI-associated integrases of Bacillus and the 
potential to transfer genetic information to S. aureus and probably other staphylococci.
Excision and circularization of McRImecD-1-McCIIMD0819 subunits. Spontaneous formation of circular DNA mol-
ecules containing mecD was tested by PCR and sequencing using divergent primers specific for mecD and int 
(primers a and e/f in Fig. 3). Two PCR products were obtained with IMD0819, one product with KM0211 and 
none with the McRImecD-2 containing strain IMD0473 (Supplementary Table S4). PCR was also performed to 
detect the chromosomal segment remaining after excision of the McRImecD-1 subunits using convergent primers 
specific for truA and cop (primers c and j in Fig. 3) and a short elongation time to avoid amplification of the 
entire insert. The resulting fragments indicated one deletion in KM0211 and two deletion variants in IMD0819 
(Supplementary Table S4). Furthermore, PCR products for possible excision of McCIIMD0819 in strain IMD0819 
were obtained using divergent (primers g and h) and convergent primer (primers i and j) pairs placed inside 
and outside of McCIIMD0819, respectively. Sequencing results confirmed circularization of McRImecD-1, composite 
Figure 4. (a) Phylogenetic tree of integrases of the tyrosine recombinase family. Colored boxes group members 
that share homologous integration sites (rpsI, gene for 30S ribosomal protein S9; sodm, superoxide dismutase 
gene; bcat, gene for branched-chain amino acid aminotransferase; guaA, GMP synthetase gene; groEL, 
chaperonin gene; rpsR, gene for 30S ribosomal protein S18; nlpA, gene for component of ABC-type metal ion 
transport system; smrB, gene for SsrA-binding protein). Analysis was performed for amino acid (aa) sequences 
using the UPGMA method in MEGA756. Host strains and genetic elements if known are indicated. References 
for the used sequences can be found in Supplementary Table S3. (b) Putative core attachment sites recognized 
by rpsI-associated integrases. For M. caseolyticus strains, the imperfect direct repeats (DR) carrying the att 
consensus sequence are indicated. For all other species the att site found at the 3′ end of the rpsI gene is given. 
The rpsI stop codon is underlined. Positions that hold variant bases are unshaded. All species, except S. aureus 
N315 and M. caseolyticus KM1352, carry an integrase gene downstream of rpsI.
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McRImecD-1-McCIIMD0819 and McCIIMD0819 caused by recombination between DRs. Consistently, the left DR 
was incorporated in the circular molecule and the right DR remained as a joining region on the chromosome 
(Supplementary Table S4). This pattern suggests site-specific as well as orientation-specific enzymatic activity 
most probably encoded by the integrase of the mecD resistance islands. Homologous recombination mediated by 
DprA protein also encoded on McRImecD-1 would lead to a random recombination of DRs. The absence of circular 
McRImecD-2 molecule in IMD0473 can be explained by the lack of flanking DRs. A 61-bp core att site representing 
a putative target for the integrase was found in the extended imperfect DR sequences. This consensus sequence 
includes the 3′ end of rpsI gene and was also found in S. aureus and Bacillus species (Fig. 4b). In M. caseolyticus, 
att-DR1 of IMD0819, KM0211 and IMD0473 were identical and specified to be part of the mecD resistance 
islands. On the other hand, att-DR2 of KM0211 included the displaced 3′ end of rpsI after McRImecD-1 insertion 
and was identical to the DR of the methicillin-sensitive strain KM1352. Notably, positions of mismatches clarified 
that cleavage for strand exchange must have taken place among the first 8 bases of the att sites (Fig. 4b).
Construction of McRImecD-1 deletion variants. To induce excision of McRImecD-1, cells were grown in the pres-
ence of subinhibitory concentrations of ciprofloxacin. This treatment has been reported to induce SOS response, 
excision of bacteriophages and the movement of SaPIs44,45. Using replica plating, two cefoxitin-susceptible clones 
were obtained from IMD0819 (2 of 251 clones tested) but none from KM0211 (0 of 445). Sequencing revealed 
excision of McRImecD-1 in the deletion mutant IMD0819_20 and the composite element McRImecD-1-McCIIMD0819 
in the deletion mutant IMD0819_33. The chromosomal segments were joined by DR2 in IMD0819_20 and DR3 
in IMD0819_33. Both strains had lost β -lactam resistance as confirmed by susceptibility measurement (Table 2).
Conclusions
The novel mecD gene has been demonstrated to confer resistance to all classes of β -lactams including anti-MRSA 
cephalosporins, ceftobiprole and ceftaroline in M. caseolyticus. A transfer to S. aureus may jeopardise the effi-
cacy of the last generation cephalosporins in MRSA. The mecD gene was located on genomic islands McRImecD-1 
and McRI-mecD-2 associated with a putative virulence gene and a site-specific integrase suggesting a potential 
for dissemination. Although a mechanism of horizontal gene transfer is not obvious due to the absence of genes 
for conjugative transfer or for interaction with phage packaging machinery, circular excisions containing mecD 
were observed. This characteristic resembles SCCmec elements that also do not encode genes for transfer but ser-
ine recombinases capable of element excision and circularization23,46. The integrase of the tyrosine recombinase 
family located on mecD-resistance islands is suggested to recognize a conserved core att site present at the 3′ end 
of rpsI gene. Conservation of this att site in Bacillus and Staphylococcus species and the detection of a similar 
rpsI-associated integrase in the S. aureus strain 930918–347 suggest a potential for mecD elements to be acquired 
also by Staphylococcus species.
The presence of novel genetic elements containing a new methicillin- resistance gene in clinical M. caseolyticus 
strains from animal origin emphasizes once again the potential of bacteria to adapt to novel environments and 
to resist antimicrobial selective pressure of β -lactam antibiotics, which are widely used in veterinary medicine.
Materials and Methods
Bacterial strains and growth conditions. The origin and characteristics of the M. caseolyticus strains 
used in this study are listed in Table 1. They were obtained from the diagnostic unit of the Institute of Veterinary 
Bacteriology at the University of Bern. The samples were taken by veterinarians for diagnostic purposes there-
fore not requiring ethical approval or a permit for animal experimentation according to the current Swiss leg-
islation (Federal Animal Protection Law, 455 (https://www.admin.ch/opc/de/classified-compilation/20022103/
index.html). Strains were routinely cultivated on trypticase soy agar plates containing 5% sheep blood (TSA-SB) 
(Becton, Dickinson and company, Franklin Lakes, NJ, USA) at 37 °C. Species identification was performed using 
matrix-assisted laser desorption/ionization time-of flight mass spectrometry (MALDI-TOF MS) (microflex LT, 
Bruker Daltonics, Bremen, Germany). The laboratory strains E. coli DH5α and S. aureus RN422048 were used 
for cloning and transformation experiments. They were cultivated in Luria-Bertani (LB) broth with shaking or 
on LB agar plates at 37 °C under aerobic conditions. The recombinant DH5α and RN4220 strains containing the 
S. aureus-E. coli shuttle vector pTSSCm33 or derived constructs were selected and routinely grown using 10 mg/l 
tetracycline in the growth medium.
DNA preparation and PCRs. Plasmid DNA and genomic DNA were isolated using the peqGOLD Plasmid 
Miniprep Kit I and the peqGOLD Bacterial DNA kit (Peqlab Biotechnologie GmbH, Erlangen, Germany), 
respectively. To improve lysis of M. caseolyticus, cells were first incubated in Solution I of the kit supplemented 
with 50 mg/l of lysostaphin (Sigma-Aldrich, St Louis, MO, USA) and 2 g/l of lysozyme (Roche Diagnostics, 
Rotkreuz, Switzerland) for 20 min at 37 °C. For analytical PCR reactions, FIREPol® DNA polymerase (Solis 
BioDyne, Tartu, Estonia) and GoTaq® Long PCR Master Mix (Promega, Madison, WI, USA) were used for short 
(< 2.5 kb) and long amplicons (up to 20 kb), respectively. Insert amplifications for plasmid construction were 
performed using High-Fidelity DNA polymerases (Pfu DNA polymerase [Promega] or the Phusion Hot Start 
II High-Fidelity DNA polymerase [Thermo Fisher Scientific, Waltham, MA, USA]) according to the manufac-
turer’s instructions. All relevant primers used in this study are listed in Supplementary Table S1. The presence 
of mecD was confirmed by PCR using primers mecD-F (5′ -TCCTTTAGCGATAGATGGTGAA) and mecD-R 
(5′ -CTCCCATCTTTTCTCCATCCT).
Genome sequencing and analysis. M. caseolyticus strains KM1352, IMD0819, IMD0473 and KM0211 
were sequenced using Illumina MiSeq technology. Genomic DNA was extracted using the UltraClean® Microbial 
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DNA Isolation Kit (MO BIO Laboratories, Carlsbad, CA, USA). Library preparation and sequencing were 
performed according to the manufacturer’s standard protocols using MiSeq Reagent kit v2 (Illumina, Little 
Chesterfield, UK) at the Labormedizinisches Zentrum Dr. Risch, Bern-Liebefeld, Switzerland. Draft genomes 
were assembled de novo using Geneious version R9.1.5 (Biomatters, Auckland, New Zealand). Contigs were ana-
lyzed for the presence of antimicrobial resistance genes using BLAST and ResFinder49. To obtain larger scaffolds 
of region of interest (required for genome of IMD0819 and IMD0473), target contigs were aligned to the chro-
mosome of M. caseolyticus JCSC5402 (GenBank: NC_011999) to identify adjacent contigs and gaps were filled 
by PCRs and Sanger sequencing (ABI PRISM 3100 genetic analyzer, Applied Biosystems, Foster City, CA, USA) 
(IMD0819: connection of contig1-contig21; IMD0473: connection of contig26-contig56-contig11). The genomic 
structure was subsequently confirmed by long-range PCR amplification and restriction analysis in all sequenced 
strains (Supplementary Table S2). Prodigal software for gene finding in prokaryotes was used to define orfs50. 
Annotation of the orfs was performed manually by BLAST homology and putative function of the translated orfs 
analyzed against Prosite entries51 and Conserved Domain Database (CDD)52. Spontaneous formation of circular 
DNA molecules and the chromosomal region remaining after excision was analyzed by PCR using specific diver-
gent and convergent primer pairs and GoTaq® Long PCR Master Mix (Supplementary Table S4). If more than one 
PCR product was obtained, fragments were gel purified prior to Sanger sequencing.
Recombinant strains. Curing of mecD from M. caseolyticus IMD0819 was carried out using cells growing 
with shaking in LB broth and in the presence of subinhibitory concentrations of ciprofloxacin (0.1 or 0.025 mg/l) 
for 6 h at 37 °C. Dilutions were plated on TSA-SB and single colonies analyzed by replica plating using LB agar 
containing 5 mg/l cefoxitin for negative selection. Deletion of mecD-containing fragments in the susceptible 
clones was determined by PCR and Sanger sequencing.
Two recombinant plasmids for mecD expression were generated in E. coli DH5α and electroporated into 
S. aureus RN422053,54. Insert sequences were obtained from M. caseolyticus strain IMD0819 through PCR ampli-
fication and introduced into the vector pTSSCm. The mecD gene including its native promoter was amplified 
with primers mecD-XhoI-F and mecD-SpeI-R (Pfu polymerase) and the mecD-mecR1m-mecIm fragment was 
obtained using primers mec-XhoI-F and mecD-SpeI-R (Phusion Hot Start II High-Fidelity DNA polymerase) 
(Supplementary Table S1). The cloning primers carried a SpeI or a XhoI site in the 5′ -overhang to facilitate liga-
tion of the PCR products into the pTSSCm vector after restriction with XhoI and SpeI endonucleases. The new 
constructs were named pTSSCm-D1 (mecD) and pTSSCm-D2 (mecD-mecR1m-mecIm). Their structures were 
verified based on restriction digestion patterns and Sanger sequencing.
Antimicrobial susceptibility testing. MICs were determined in Müller-Hinton broth through the 
microdilution technique16 using Sensititre EUST and EUVSEC2 plates (Thermo Fisher Scientific). Additionally, 
MICs of oxacillin (OXA), cefoxitin (FOX), penicillin (PEN), ceftobiprole (CBP) and ceftaroline (CRL) were 
determined using serial two-fold dilutions ranging from 0.25 mg/l to 128 mg/l (for OXA, FOX and PEN) and 
0.125 mg/l to 64 mg/l (for CBP and CRL). Stock solution of ceftobirole (BAL0009141, Batch: 08004R25F) (Basilea 
Pharmaceutica AG, Basel, Switzerland) was prepared as described55. The dephosphorylated active form of cef-
taroline (U3, Batch: CI 148/09) (AstraZeneca, Cambridge, UK) was freshly dissolved in 0.1 M sodium phosphate 
pH 7.5 at 1 mg/ml prior use. The production of β -lactamase was tested on BBL™ DrySlide™ Nitrocefin (Becton, 
Dickinson and Company).
Data Availability. The nucleotide sequences of mecD resistance islands and flanking regions have been 
deposited in the GenBank under the accession number KY013611 for M. caseolyticus IMD0819, KY013612 for 
M. caseolyticus KM0211, KY013610 for M. caseolyticus IMD0473 and KY013613 for M. caseolyticus KM1352.
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